The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) ...

New research reveals stem cell therapy significantly lowers heart failure risk in heart attack survivors. Patients receiving ...

BETAMI-DANBLOCK evaluates whether discontinuation of beta-blockers after MI is safe in patients with preserved or mildly ...

Of note, the iMODERN trial had also excluded people with a history of prior STEMI, chronic total occlusion, complex ...

Though patients with type 2 diabetes or chronic kidney disease (CKD) face a greater risk of heart failure (HF) following acute myocardial infarction (AMI), patients without those comorbidities also ...

Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 ...

Myocardial infarction is one of the leading causes of death in the world, especially among the elderly with an increased risk of cardiovascular diseases. Many people believe that alcohol is the main ...

In separate treatment trials, one for de novo coronary lesions and the other for in-stent restenosis, a sirolimus-eluting ...

The American College of Surgeons has recognized 51 U.S. hospitals for achieving “meritorious” outcomes for surgical patients in 2024. The distinction is part of the ACS National Surgical Quality ...

This page lists all known medications that could potentially lead to 'Myocardial infarction' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

A study has explored how Halloween habits may impact heart health, offering insights for clinicians and public awareness.